[Form 4] CHEMED CORP Insider Trading Activity

Rhea-AI Filing Summary

Chemed Corp. insider Kevin J. McNamara, who serves as director, president and CEO, reported a sale of company stock. On 11/24/2025, he sold 2,000 shares of Chemed capital stock in an open market transaction coded as "S" for sale. The weighted average sale price was $437.55 per share, with individual trade prices ranging from $436.13 to $438.53.

After this transaction, McNamara beneficially owns 94,197 shares of Chemed stock in direct form. He has indicated a willingness to provide detailed breakdowns of the number of shares sold at each separate price within the reported range to Chemed, its security holders, or SEC staff upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	president and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	11/24/2025		S		2,000	D	$437.55(1)	94,197	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.13 to $438.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

	Kevin J. McNamara	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CHEMED CORP (CHE) report for Kevin J. McNamara?

Chemed Corp. reported that Kevin J. McNamara, its director, president and CEO, sold 2,000 shares of Chemed capital stock on 11/24/2025 in a transaction coded as a sale ("S").

At what price were the 2,000 CHEMED CORP (CHE) shares sold?

The weighted average sale price for the 2,000 Chemed shares was $437.55 per share. The shares were sold in multiple trades at prices ranging from $436.13 to $438.53.

How many CHEMED CORP (CHE) shares does Kevin J. McNamara own after this transaction?

Following the reported sale, Kevin J. McNamara beneficially owns 94,197 Chemed shares, held as a direct ownership position.

What is Kevin J. McNamara’s role at CHEMED CORP (CHE)?

Kevin J. McNamara is both a director and an officer of Chemed Corp., serving as the company’s president and CEO.

How were the price details of the CHEMED CORP (CHE) insider sale reported?

The filing states that the price in Column 4 is a weighted average. The shares were sold in multiple transactions between $436.13 and $438.53, and McNamara undertakes to provide the exact breakdown of shares sold at each price upon request.

Is this CHEMED CORP (CHE) filing for a single reporting person or a group?

The Form 4 is indicated as being filed by one reporting person, specifically Kevin J. McNamara.